How Often Is Mounjaro Injected, and What Does the Schedule Look Like?

Why once a week, and does the day of the week actually matter?

Tirzepatide has a half-life long enough to maintain steady levels with a single weekly injection. That's what makes the once-weekly schedule practical rather than arbitrary. You pick a day that fits your week (Monday morning, Sunday evening, whatever is easiest to remember) and you stick to it.

The day itself doesn't matter clinically, but consistency does. Spacing injections roughly seven days apart keeps drug levels stable. If you need to shift your injection day by a couple of days occasionally, the NHS guidance suggests this is manageable, but for the specifics of timing shifts and missed doses, the NHS tirzepatide medicines page and your Patient Information Leaflet are the places to check, not a forum, not an app.

A question our prescribers hear most weeks is whether it matters if the injection is at the same time of day each week, and if you want a thorough answer, our guide to how often you take Mounjaro injections covers the nuances in full. Mounjaro can be taken at any time, with or without food. Time-of-day consistency is helpful for building a habit, but it is not a clinical requirement in the way that weekly spacing is.

You can inject into the abdomen, thigh or upper arm. Rotating the exact spot within each site (rather than using the same patch of skin repeatedly) reduces the chance of local reactions. The injection sites guide covers technique in more detail.

Does how often you inject change as the dose goes up?

No. The frequency stays at once weekly throughout every stage of treatment. What changes is the strength of each dose. UK-licensed Mounjaro comes in six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg. Treatment starts at 2.5 mg (this is a tolerability dose, designed to let your system adjust before therapeutic doses begin) and a prescriber reviews whether to increase after four weeks at each level.

Not everyone reaches 15 mg, and there is no obligation to. The prescriber finds the highest dose you tolerate well and that produces a meaningful response. NICE's appraisal of tirzepatide notes that if someone has lost less than 5% of their body weight after six months at the highest tolerated dose, continuing treatment should be reviewed. That review is a clinical conversation, not an automatic stop.

The titration schedule is one reason why understanding tirzepatide's dosing steps matters before you start: it sets realistic expectations. You are not on the full dose from week one, and that is by design.

At every stage (starting dose, increase, or repeat supply) a prescriber should be looking at how you are getting on. At nume, that clinical review happens before every order, not just at the beginning.

What should you do between injections?

Store your pen in the fridge at 2–8°C. Once a pen is in use it can be kept out of the refrigerator for a limited period, but for a clear explanation of how often the Mounjaro injection is given and what that means for storage between doses, the Patient Information Leaflet and the eMC (electronic Medicines Compendium) are the places to check, not memory. Never freeze the pen and keep it out of direct sunlight.

Between doses, the practical work is nutritional: protein adequacy, staying hydrated, and keeping active. Appetite suppression means some people undereat, which can lead to muscle loss over time. Your prescriber or a dietitian can advise on what to eat alongside treatment, this page covers the schedule, not the full lifestyle picture.

Dispose of used needles in a proper sharps bin. A 1-litre sharps container is the standard household size and should be sealed and returned to a pharmacy or household waste site when full, not put in general rubbish.

If you are thinking about whether Mounjaro is the right fit for you, or you want to know what a private prescription route looks like, the free consultation page is the starting point, a real prescriber reads your answers the same day.

Is the weekly injection schedule the same on the NHS and privately?

Yes. The licensed medicine is the same product regardless of how you access it, so the injection schedule is identical. The difference lies in the route to getting a prescription and the support around it.

On the NHS, access to tirzepatide is being phased in gradually, currently limited to people with a BMI of 40 or above and four or more specific weight-related conditions, with further cohorts planned through 2026 and 2027. Many people who are clinically eligible for Mounjaro do not yet meet the NHS threshold or would face a significant wait through specialist services.

A private prescription through a GPhC-registered pharmacy like nume is the alternative: no referral, no waiting list, subject to the prescriber's clinical assessment. Eligibility for private treatment follows the licensed criteria, broadly, adults with a BMI of 30 or above, or 27 or above with a weight-related condition. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance.

If you want a clearer sense of what private treatment costs (including what an honest all-in price should cover) the Mounjaro private prescription guide runs through that without any awkward omissions. The injection schedule will be the same either way: once a week, every week.